Drugs by condition
Drugs approved for migraine
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
36
Still marketed, NDA or BLA
Drug classes
6
Novel drugs
13
New molecular entities and new biologics
In development
8
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for migraine.
- Brekiya (Autoinjector) (Dihydroergotamine Mesylate) · Amneal May 14, 2025
- Atzumi (Dihydroergotamine Mesylate) · Satsuma Pharms Apr 30, 2025
- Symbravo (Meloxicam, Rizatriptan Benzoate) · Axsome Jan 30, 2025
- Rizafilm (Rizatriptan Benzoate) · Gensco Apr 14, 2023
- Zavzpret (Zavegepant Hydrochloride) · Pfizer NovelMar 9, 2023
All approved drugs for migraine, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 164 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Serotonin-1b and Serotonin-1d Receptor Agonist (3)
Calcitonin Gene-related Peptide Receptor Antagonist (2)
Nonsteroidal Anti-inflammatory Drug (2)
Calcitonin Gene-related Peptide Antagonist (1)
- Vyepti Eptinezumab-Jjmr · Lundbeck Seattle Biopharmaceuticals, Inc. · 2020
Acetylcholine Release Inhibitor (1)
- Botox Cosmetic Onabotulinumtoxina · Allergan · 1991
Class not listed in FDA's data (27)
- Zavzpret Zavegepant Hydrochloride · Pfizer · 2023
- Nurtec Odt Rimegepant Sulfate · Pfizer · 2020
- Emgality Galcanezumab-Gnlm · Eli Lilly and CO · 2018
- Ajovy Fremanezumab-Vfrm · Teva Pharms USA · 2018
- Aimovig Erenumab-Aooe · Amgen INC · 2018
- Relpax Eletriptan Hydrobromide · Upjohn · 2002
- Maxalt Rizatriptan Benzoate · Organon LLC · 1998
- Topamax Topiramate · Janssen Pharms · 1996
- Imitrex Statdose (Autoinjector) Sumatriptan Succinate · Glaxosmithkline · 1992
- Brekiya (Autoinjector) Dihydroergotamine Mesylate · Amneal · 2025
- Atzumi Dihydroergotamine Mesylate · Satsuma Pharms · 2025
- Rizafilm Rizatriptan Benzoate · Gensco · 2023
- Eprontia Topiramate · Azurity · 2021
- Trudhesa Dihydroergotamine Mesylate · Impel Pharms · 2021
- Zembrace Symtouch (Autoinjector) Sumatriptan Succinate · Tonix Meds · 2016
- Qudexy Xr Topiramate · Upsher Smith Labs · 2014
- Trokendi Xr Topiramate · Supernus Pharms · 2013
- Cambia Diclofenac Potassium · Cosette · 2009
- Treximet Naproxen Sodium, Sumatriptan Succinate · Azurity · 2008
- Depakote Er Divalproex Sodium · Abbvie · 2000
- Topamax Sprinkle Topiramate · Janssen Pharms · 1998
- Maxalt-Mlt Rizatriptan Benzoate · Organon · 1998
- Migranal Dihydroergotamine Mesylate · Bausch · 1997
- Imitrex Sumatriptan Succinate · Glaxosmithkline · 1995
- Depakote Divalproex Sodium · Abbvie · 1989
- Inderal La Propranolol Hydrochloride · Ani Pharms · 1983
- Depakote Divalproex Sodium · Abbvie · 1983
Drugs in development for migraine
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- CorabotaseIPN10200Phase 37 trials
Ipsen · Moderate to Severe Glabellar Lines, Spasticity, Moderate to Severe Upper Facial Lines
- BR005-036CPhase 32 trials
Brise Pharmaceuticals Co., Ltd. · Migraine, With or Without Aura
- AXS-07meloxicam-rizatriptanPhase 31 trial
Axsome Therapeutics, Inc. · Migraine
- EVO756Phase 24 trials
Evommune, Inc. · Migraine, Chronic Inducible Urticaria, Atopic Dermatitis
- BHV-2100Phase 21 trial
Biohaven Therapeutics Ltd. · Migraine
- MEDI0618Phase 21 trial
AbbVie · Migraine
- MTX101Phase 21 trial
Manistee Therapeutics · Migraine
- PRT-064040Phase 21 trial
Sichuan Purity Pharmaceutical Technology Co., Ltd. · Migraine
1 discontinued brand-name drugs whose label still names it
- Reyvow Lasmiditan Succinate
More on migraine: recruiting trials · published research
Related in neurology: Alzheimer's disease · Parkinson's disease · Multiple sclerosis · Epilepsy and seizures · ALS (amyotrophic lateral sclerosis) · Myasthenia gravis · Spinal muscular atrophy · Duchenne muscular dystrophy · Huntington's disease chorea · Tardive dyskinesia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.